Latest filing published 10 Feb 2026 for BIOGEN INC..
Ginger Gregory, EVP, Human Resources at Biogen Inc., the only company in the record, has 66 filings published from August 3, 2017 to February 10, 2026. Market trades there are limited to 2 sales: EUR 1,630,061 on November 14, 2022 and EUR 729,058 on April 28, 2023, EUR 2,359,119 in all. No purchase appears. The rest is 37 share grants and 27 option exercises.
The yearly count of filings goes from 1 in 2017 to 9 in 2020, 2022 and 2023, with 8 in 2021 and in 2024, and 6 in 2025 and in 2026. The 6 filings of the last twelve months include neither a purchase nor a sale. The median publication lag is 4 days after the trade, across 66 dated filings.
Two Biogen colleagues appear in the same weeks as Gregory's sales, each with a single trade and in the same direction: Priya Singhal and Susan H. Alexander. Neither of the 2 sales is followed by a purchase.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 69 declarations